
Grants Awarded
Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.
New awards will be posted as they are issued.
Year | Award Type | Project # | RFA # | PI/Project Leader | Institution | Title |
Status![]() |
---|---|---|---|---|---|---|---|
2020 | R21 | CA246457 | RFA-CA-19-019 | HATTORI, TAKAMITSU | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications | Active |
2019 | R33 | CA229042 | RFA-CA-18-003 | SCHNECK, JONATHAN P | JOHNS HOPKINS UNIVERSITY | A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells | Active |
2018 | R33 | CA229023 | RFA-CA-17-011 | TEWARI, MUNEESH (contact); WALTER, NILS G | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations | Active |
2022 | R21 | CA272014 | CA21-003 | SALIPANTE, STEPHEN J | UNIVERSITY OF WASHINGTON | Efficient, cost-effective, and ultrasensitive sequencing of somatic mutations | Active |
2020 | R33 | CA236670 | RFA-CA-19-020 | HIGGINSON, DANIEL | SLOAN-KETTERING INST CAN RESEARCH | Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways | Active |
2019 | R33 | CA229068 | RFA-CA-18-003 | SCHIAVINATO EBERLIN, LIVIA | UNIVERSITY OF TEXAS, AUSTIN | Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation | Active |
2018 | R21 | CA229037 | RFA-CA-17-012 | GULLEY, MARGARET L | UNIV OF NORTH CAROLINA CHAPEL HILL | EndoGenus Toolkit: A Biometric Method for Absolute Quantification of Tumor Markers by Massive Parallel Sequencing | Active |
2022 | R21 | CA272014 | CA21-003 | NABA, ALEXANDRA | UNIVERSITY OF ILLINOIS AT CHICAGO | Enhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrix | Active |
2020 | R21 | CA240185 | RFA-CA-19-019 | LI, WEI | TEXAS TECH UNIVERSITY | Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip | Active |
2019 | R33 | CA235254 | RFA-CA-18-003 | FIOLKA, RETO PAUL | UT SOUTHWESTERN MEDICAL CENTER | Multiscale microscope for 3D cancer imaging in model organisms and organoids | Active |
2022 | R21 | CA267245 | CA21-005 | SHIBATA, DARRYL K | UNIVERSITY OF SOUTHERN CALIFORNIA | Photolithographic Tumor DNA Isolation | Active |
2020 | R21 | CA247638 | RFA-CA-19-019 | LIANG, FU-SEN | CASE WESTERN RESERVE UNIVERSITY | Spatiotemporal Epitranscriptome Editing Technology | Active |
2019 | R33 | CA235302 | RFA-CA-18-003 | DE VLAMINCK, IWIJN | CORNELL UNIVERSITY | Spatially Resolved Metagenomics to Explore Tumor-Microbiome Interactions in Human Colorectal Cancer | Active |
2022 | R33 | CA267219 | CA21-004 | LANDAU, DAN | WEILL MEDICAL COLL OF CORNELL UNIV | Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes | Active |
2020 | R44 | CA236097 | PAR-18-303 | LIM, MARK | AMBERGEN, INC | Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues | Active |
2019 | R33 | CA235319 | RFA-CA-18-003 | YANG, JENNY J. | GEORGIA STATE UNIVERSITY | Multi-color Mapping of Cancer Molecular Signatures and Tumor microenvironment | Active |
2018 | R33 | CA217702 | RFA-CA-17-013 | BORGES, CHAD R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity | Active |
2022 | R33 | CA272321 | CA21-004 | WANG, TZA-HUEI JEFF | JOHNS HOPKINS UNIVERSITY | A low-cost, multiplexed digital high resolution melt platform for DNA methylation-based detection and identification of cancers in liquid biopsies | Active |
1999 | R21 | CA081658 | PAR-98-067 | VIDAL, MARC | MASSACHUSETTS GENERAL HOSPITAL | NEW TECHNOLOGIES FOR PROTEIN INTERACTION MAPPING | Complete |
2001 | R33 | CA086132 | PAR-99-100 | MAJUMDAR, ARUNAVA | UNIVERSITY OF CALIFORNIA BERKELEY | OPTOMECHANICAL CHIPS FOR MOLECULAR PROFILING OF CANCER | Complete |
2003 | R44 | CA099117 | PAR-01-105 | NEDELKOV, DOBRIN | INTRINSIC BIOPROBES, INC. | AFFINITY-BASED MASS SPECTROMETRY PROTEIN ASSAYS | Complete |
2007 | R21 | CA126674 | RFA-CA-07-002 | GARRAWAY, LEVI ALEXANDER | DANA-FARBER CANCER INST | HIGH-THROUGHPUT ONCOGENE MUTATION DETECTION IN HUMAN CANCER | Complete |
2009 | R44 | CA134258 | RFA-CA-07-039 | GUO, BAOCHUAN | GLC BIOTECHNOLOGY, INC. | MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY | Complete |
2013 | R33 | CA182377 | RFA-CA-13-002 | BROWN, BRIAN DAVID | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | SENSOR-SEQ: A GENOME-WIDE BIOLOGICAL MEASURE OF MICRORNA ACTIVITY. | Complete |
2017 | R21 | CA204708 | RFA-CA-16-001 | MALMSTADT, NOAH | UNIVERSITY OF SOUTHERN CALIFORNIA | A Target-Directed Reagent Pipeline via Microfluidic mRNA Display | Complete |
2000 | R43 | CA086413 | PAR-99-101 | KOGON, ALEX A | BIOLINX, LLC | THOMSEN-FRIEDERICH ANTIGEN ASSAY FOR CANCER SCREENING | Complete |
2002 | R43 | CA097483 | PAR-01-105 | HANNA, MICHELLE M | RIBOMED BIOTECHNOLOGIES, INC. | RAPID ANALYSIS OF CPG METHYLATION CHANGES IN CANCER | Complete |
2006 | R21 | CA123006 | RFA-CA-06-004 | HSI, ERIC | CLEVELAND CLINIC LERNER COL/MED-CWRU | CHARACTERIZATION OF METHODS FOR PRESERVATION OF PHOSPHOPROTEINS IN FIXED TISSUES | Complete |
2009 | R21 | CA134419 | RFA-CA-08-006 | MC GOWN, LINDA B. | RENSSELAER POLYTECHNIC INSTITUTE | HYBRIDIZATION OF PROMOTER DNA TARGETS IN CHROMATIN TO DISCOVER REGULATORY PROTEIN | Complete |
2013 | R21 | CA174583 | RFA-CA-12-002 | CASTRO, CARLOS E. | OHIO STATE UNIVERSITY | NANOSCALE TOOLS FOR FUNCTIONAL STUDIES OF CANCER-RELEVANT CHROMATIN MODIFICATIONS | Complete |
2016 | R21 | CA186842 | RFA-CA-15-002 | SADEGHI , SAMAN | UNIVERSITY OF CALIFORNIA LOS ANGELES | ELECTROCHEMICAL SYNTHESIS OF RADIOPHARMACEUTICALS | Complete |
2000 | R21 | CA086136 | PAR-99-102 | GRIFFITH, JEFFREY K | UNIVERSITY OF NEW MEXICO | PROGNOSTIC VALUE OF TELOMERE DNA IN PROSTATE BIOPSY | Complete |
2002 | R33 | CA084697 | PAR-98-067 | SHERRY, A. DEAN | UNIVERSITY OF TEXAS DALLAS | MRI AGENTS SENSITIVE TO BIOLOGICAL INDICATORS OF NEOPLAS | Complete |
2005 | R33 | CA114184 | RFA-CA-05-003 | FU, XIANG-DONG | UNIVERSITY OF CALIFORNIA SAN DIEGO | TYPING THE TRANSCRIPTOME IN CANCER USING SPLICING ARRAY | Complete |
2008 | R21 | CA118592 | RFA-CA-07-037 | KNUDSEN, BEATRICE S | FRED HUTCHINSON CANCER RESEARCH CENTER | TISSUE LYSATES FOR STUDIES OF PROTEIN PHOSPHORYLATION | Complete |
2011 | R21 | CA160080 | RFA-CA-10-005 | SHENDURE, JAY ASHOK | UNIVERSITY OF WASHINGTON | ULTRASENSITIVE IDENTIFICATION AND PRECISE QUANTITATION OF LOW FREQUENCY SOMATIC M | Complete |
2015 | R33 | CA191198 | RFA-CA-14-004 | CARON, MARC G. | DUKE UNIVERSITY | A CANCER RAINBOW MOUSE FOR SIMULTANEOUS ASSESSMENT OF MULTIPLE ONCOGENES | Complete |
2018 | R33 | CA214310 | RFA-CA-17-013 | INCE, TAN A. | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | Live Tumor Culture Core and Tissue Specific Culture (TSC) System for Human Cancers | Complete |
1999 | R43 | CA083384 | PAR-98-066 | RICHTERICH, PETER | CODONCODE CORPORATION | SOFTWARE FOR SEQUENCING BASED MUTATION DETECTION | Complete |
2002 | R21 | CA095942 | PAR-01-104 | YEUNG, EDWARD S. | IOWA STATE UNIVERSITY | SINGLE-MOLECULE IMMUNOASSAY AND DNA SCREENING | Complete |
2004 | R44 | CA105539 | PAR-01-105 | BATTRELL, CHARLES FRED | MICRONICS, INC. | MICROFLUIDIC POINT-OF-CARE CANCER CELL ANALYZER | Complete |
2007 | R43 | CA128752 | RFA-CA-07-010 | KRAVITZ, RACHEL HANNAH | NEOCLONE BIOTECHNOLOGY INTERNATIONAL | A NOVEL PLATFORM FOR MINING THE REPERTOIRE OF ANTIGEN-SPECIFIC B CELLS | Complete |
2010 | R33 | CA143531 | RFA-CA-09-007 | CLAFFEY, KEVIN P. | UNIVERSITY OF CONNECTICUT SCH OF MED/DNT | DISCOVERY PLATFORM FOR CANCER ANTIGENS | Complete |
2014 | R43 | CA188154 | PAR-13-327 | FELLMANN, CHRISTOF | MIRIMUS, INC. | RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO | Complete |
2021 | R33 | CA256112 | CA20-018 | WEI, WEI | INSTITUTE FOR SYSTEMS BIOLOGY | Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy | Complete |
1999 | R21 | CA081656 | PAR-98-067 | GARNER, HAROLD R | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES | Complete |
2001 | R33 | CA088198 | PAR-99-100 | HERLYN, DOROTHEE M | WISTAR INSTITUTE | MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS | Complete |
2003 | R44 | CA099126 | PAR-01-105 | ZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC. | ARTIFICIAL ANTIBODY MIMETICS | Complete |
2007 | R21 | CA125288 | RFA-CA-07-002 | SEGALL, JEFFREY E | ALBERT EINSTEIN COLLEGE OF MEDICINE | DEVELOPMENT OF AN IN VIVO METASTASIS SCREEN | Complete |
2009 | R44 | CA134310 | RFA-CA-07-041 | LEE, BRIAN W | IMMUNOCHEMISTRY TECHNOLOGIES, LLC | NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO | Complete |